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Introduction 16 
Fluorescence in situ Hybridisation (FISH) revolutionised the study of cytogenetics in the late 1980s, 17 
enabling basic scientists and clinicians to visualise specific chromosome regions within the nucleus. It 18 
provided, for the first time, a direct link between the microscope and DNA sequence. The technique 19 
uses fluorescently labelled short stretches of DNA (probes) that have a high level of sequence 20 
complementarity to specific sections of a chromosome. Following denaturation of chromosomal 21 
(target DNA) and probe, hybridisation is allowed to occur under specific conditions (e.g. 22 
temperature, concentration of formamide) to allow high affinity between target and probe DNA. By 23 
the early 1990s FISH was adopted by fertility centres worldwide as means of sex determination in 24 
preimplantation embryos from couples at risk of transmitting X-linked disorders [1, 2]. Shortly after, 25 
FISH found additional roles in the identification of unbalanced translocations and in chromosome 26 
copy number screening (e.g. embryo, sperm aneuploidy). Since then, the rapid increase in the use of 27 
in vitro fertilisation (IVF) and preimplantation genetic diagnosis (PGD) globally has not only enabled 28 
huge advancements in reproductive medicine, but has also provided a unique opportunity to study 29 
the cytogenetics of human embryos at the earliest stages of development. With the ultimate goal of 30 
developing diagnostic tests and improving patient care, those embryos produced by IVF cycles that 31 
are not deemed for transfer represent a valuable source of sample material under appropriate 32 
ethical justification. Nowadays, FISH has been replaced with newer technologies for the purposes of 33 
PGD using single cells; first by array CGH, then by single nucleotide polymorphism arrays (SNP) or 34 
quantitative real-time polymerase chain reaction (qRT-PCR) and most recently by next generation 35 
sequencing (NGS) [3]. Concurrently with the application of these newer technologies, the platform 36 
of evaluating the chromosomal status of preimplantation embryos has shifted from blastomere to 37 
trophectoderm biopsy (blastocyst stage). Despite the advancement in technologies, the cell-by-cell 38 
analysis of blastomeres or available blastocysts within an embryo with the new techniques is still 39 
prohibitively expensive. As a result, FISH remains very much an invaluable resource for the study of 40 
cytogenetics in preimplantation embryos in terms of evaluating the level of mosaicism and at a more 41 
research level the nuclear organisation of chromosomes at this early stage of development. The 42 
purpose of this review is to give an overview of the history of FISH in PGD/PGS, cover the reasons 43 
why it fell out of favour and indicate how it may, with recent adaptations, be used as a tool for 44 
research and “follow up” of clinical cases. 45 
 46 
A brief history of FISH and its use for PGS 47 
The assessment of chromosome copy number in preimplantation embryos is the essence of 48 
preimplantation genetic screening (PGS), a commonly elected procedure in couples where advanced 49 
maternal age (AMA), recurrent miscarriage, recurrent implantation failure (RIF) or male factor 50 
infertility is implicated. It is widely believed that aneuploidy (presence of an extra or missing 51 
chromosome) is present in approximately 0.6% of live newborn infants, 6% of stillbirths, and 60% of 52 
spontaneous abortions [9, 10]. Moreover, numerical chromosome abnormalities are present in 60-53 
70% of embryos generated by IVF (at the blastomere stage) [11-14], whereas it can reach levels of 54 
>50% in the blastocyst stage [15]. Although the majority of chromosome copy number abnormalities 55 
are lethal, aneuploidies involving a few specific chromosomes survive to term. On this basis, 56 
following a rise in the use of FISH for sex determination in the early 1990s and the availability of 57 
multicolour probes, the use of FISH was expanded to the detection of aneuploidy in order to 58 
selectively implant embryos more likely to be fully euploid.  59 
 60 
The rationale behind the use of PGS in infertile couples requiring assisted reproductive technology 61 
(ART), is to increase pregnancy rates, since morphology alone does not suffice to distinguish a 62 
euploid from an aneuploid embryo. Therefore, by transferring euploid embryos, the chances of a 63 
viable pregnancy should be higher. The logic of this hypothesis is generally accepted in the field of 64 
reproductive medicine and can have particular application in women of AMA, couples with RIF, 65 
repeated miscarriage or severe male factor infertility [20, 21]. Initially from the 1990s to 2010, FISH 66 
was used to perform diagnosis on the chromosomal complement of polar bodies and blastomeres 67 
[22, 23]. A total of eight chromosomes, six autosomal chromosomes (13, 15, 16, 18, 21 and 22) and 68 
the sex chromosomes were more commonly tested in IVF clinics through PGS as these were known 69 
to be involved in aneuploidies detected in spontaneous abortions and in trisomic live births [11, 24]. 70 
Despite the initial reports for an increase in implantation rates, reduction in trisomic offspring and 71 
spontaneous abortions [25, 26], criticism emerged since these reports were non-randomised, had 72 
poor experimental design, inadequate control groups and lack of report on live births [26]. 73 
 74 
From 2004 to 2010, eleven randomised control trials (RCTs) showed that PGS with FISH did not 75 
increase delivery rates, some studies showed the contrary and sparked a huge debate in the field. 76 
The reasons [26-29] for the reduced efficiency of PGS-FISH are beyond the scope of this review 77 
however they extended from technique-inherent limitations to biological (e.g. high levels of 78 
mosaicism in cleavage stage embryos, biopsy stage). This opened up different methodological 79 
approaches for the analysis of all chromosomes using genome wide platforms (e.g. aCGH, SNP-array, 80 
NGS), prompted multi-centre RCTS [30, 31] and parallel with improvements in culturing [32] and 81 
cryopreservation of embryos (e.g., vitrification) [33, 34] the diagnostic platform was shifted from day 82 
3 to day 5 (blastocysts), making at the same time FISH an outdated technology for the complete 83 
chromosomal complement analysis in a PGS setting.  84 
 85 
24 chromosome FISH on single cells  86 
During the time since FISH was first popularised, the technique has evolved considerably to see the 87 
development of directly labelled, multicolour, commercially available probes with shorter 88 
hybridisation times and greater hybridisation efficiencies, which has enabled the ability to study up 89 
to 12 chromosomes within the same nucleus at once [4]. Better still, whole chromosome paints for 90 
all 24 chromosomes soon became commercially available by mixing fluorochromes to produce 91 
secondary colours. However, the difficulty with taking this approach is that overlapping signals in the 92 
interphase nucleus are not easily distinguishable from one another. To circumvent this problem 93 
therefore, we developed a new ‘multilayer’ approach to 24-chromosome FISH, enabling 94 
comprehensive analysis of copy number for each chromosome in the karyotype. Based on a 95 
previously published protocol termed ‘re-FISH’, six spectrally distinct probes were used, in four 96 
consecutive rounds of FISH to visualise all 24 chromosomes [5]. The setup of 6 fluorochromes and 4 97 
rounds of hybridization was selected to maximise the outcome of chromosome copy number, while 98 
reducing the rounds of re-probing of nuclei and thus increase the chances of signal efficiency. In 99 
addition the probes for the chromosomes that constitute each round of hybridisation were 100 
categorised based on availability of centromeric sequences for that particular chromosome or not.  101 
 The first three rounds of hybridisation (that can be inter-changeable) use probes against 102 
centromeric sequences; round one for chromosomes 1, 3, 4, 6, 7 and 8, round two for chromosomes 103 
9, 10, 11, 12, 17 and 20, round three for chromosomes 2, 15, 16, 18, X, Y whereas the fourth round 104 
uses unique sequence targets for 6 chromosomes that do not have unique centromeric probes, 105 
chromosomes 5, 13, 14, 19, 21 and 22. The protocol can be completed within 24 hours, since the 106 
hybridisation times for the centromeric layers is 15-30 minutes and overnight for the unique 107 
sequence layer, fitting in a clinical setting and tailored for different applications (e.g. embryo versus 108 
sperm aneuploidy). The fast hybridisation times for the centromeric layers are possible due to the 109 
highly repetitive sequences (α-satellite) used to generate the respective probes. 110 
 111 
 A bespoke capturing system is necessary in order to be able to image all fluorochromes in separate 112 
channels plus the DAPI counterstain in a different channel. In-house, we used a modified version of 113 
Digital Scientific’s SmartCapture, and this novel approach that has been previously validated in 114 
different cell types [5], offers a powerful research tool in the identification of chromosome copy 115 
number that can be applied to different cell types. It also allows for the simultaneous assessment of 116 
nuclear organisation; that is, the so-called “nuclear address” of chromosomes (or sub-chromosomal 117 
regions and/or loci) within the nucleus. For this feature a custom-script for Image J (freely-118 
downloadable software) is required and more details have been previously published here [6, 7]. 119 
The main advantage of this approach is the ability to assess the levels of mosaicism in individual cell 120 
populations, particularly early human preimplantation development. While cell-by-cell analysis is 121 
certainly technically feasible (and potentially more accurate) using array CGH or NGS, the costs 122 
involved are prohibitively expensive. Practical applications include the “follow up” validation of PGS 123 
cases and assessing the levels of mosaicism in cleavage stage, morula or blastocyst embryos. In the 124 
latter case, blastulation represents the first visible stage of differentiation of the human embryo and 125 
study of mosaicism at this stage is attracting great interest in the scientific literature at the moment 126 
[8].  127 
 128 
The methodology  129 
Material used for our studies have been mostly “follow up” aneuploid PGS cases, the collaborating 130 
clinics were the London Bridge Fertility Centre and the Lister Fertility Clinic. The protocol involves six 131 
Kreatech fluorochromes, namely PlatinumBright™: 405 (blue), 415 (light blue/aqua), 495 (green), 132 
547 (light red/orange), 590 (dark red), 647 (far red) plus the DAPI counterstain in a four-stage 133 
probing and re-probing strategy. All probes for this protocol were synthesized by Kreatech 134 
Diagnostics using the Universal Linkage Labeling System (KBI-40060): 135 
http://www.kreatech.com/rest/products/repeat-freetm-poseidontm-fish-dna-136 
probes/preimplantation-genetic-screening/multistar-24-fish.html, including six unique sequence 137 
targets for chromosomes 5, 13, 14, 19, 21 and 22 and the remaining 18 centromeric probes. These 138 
are shown in figures 1 and 2. The highly repetitive nature of the remaining unique centromeric 139 
targets meant that hybridisation times could be reduced to 15-30 minutes, however the unique 140 
sequence probes required overnight hybridisation. The choice of fluorochromes for each individual 141 
probe relied on combining the strongest signals with the least strong fluorochromes and vice versa. 142 
For instance chromosome 18 (one of the brightest and most reliable probes) was labelled with the 143 
blue (the least bright) fluorochrome. Table 1 illustrates the final probe-fluorochrome combinations. 144 
Human IVF embryo nuclei are fixed to slides by standard protocols; slides are washed in PBS for 2 145 
minutes and dehydrated and dried using an ethanol series. Pepsin treatment removes excess protein 146 
(1 mg/ml pepsin in 0.01 M HCl, 20 min at 37 °C), then the slides are rinsed in distilled water and PBS, 147 
followed by a paraformaldehyde (1% in PBS) fix at 4 °C for 10 min, followed by another PBS and 148 
distilled water wash and an ethanol dehydration and drying step. The four probe combinations are 149 
dissolved in hybridization mix (Kreatech standard protocols). It is important to pre-denature the 150 
probes at 73 °C for 10 min before application on the slide, then co-denaturation of probe and 151 
chromosomes proceeds at 75°C for 90 seconds in a “Thermobrite-StatSpin” before hybridization at 152 
37°C. The hybridization period for the first three (alpha, beta, gamma) rounds of hybridization 153 
(centromeric probes) is for 30 min, whereas for the final round (omega), it is overnight. Post-154 
hybridization washes are for 1 min 30 s in 0.7× SSC, 0.3%Tween 20 at 72 °C followed by a 2 min in 155 
2×SSC at room temperature. Slides are mounted in Vectashield containing 0.1 ng/μl of DAPI (Vector 156 
labs) before microscopy and image analysis. After analysis and image capture, slides are washed in 157 
2×SSC at room temperature to remove the coverslip and then washed for 30 seconds in distilled 158 
water (72°C) to remove the bound probe. An ethanol series precedes air-drying before continuation 159 
to the next round of hybridization. The protocol is the same for the second, third and final rounds 160 
with the following exceptions: The overnight hybridization time for the final round (previously 161 
mentioned), pepsin and paraformaldehyde treatment are only required for the first round; the post-162 
hybridization wash time is reduced with every round from 90 s (first round of hybridization) to 50–60 163 
s (second round) to 30 s (third and final rounds). Microscopy analysis, at least in our hands, is 164 
performed on an Olympus BX-61 epifluorescence microscope equipped with a cooled CCD camera 165 
(by Digital Scientific—Hamamatsu Orca-ER C4742-80) and using the appropriate filters. To enable 166 
analysis of the fluorochromes for image acquisition two communicating filter wheels (Digital 167 
Scientific UK) with the appropriate filters were used. The recommended filters by the probe 168 
manufacturers can be found here: http://www.kreatech.com/rest/customer-service-169 
support/technical-support/fluorophores-and-filter-recommendation.html and the image capture 170 
system was SmartCapture (Digital Scientific UK). 171 
 172 
Chromosome mosaicism in human preimplantation development  173 
Early studies that assessed chromosome copy number in IVF preimplantation embryos discovered 174 
that a large proportion of human embryos are mosaic. The incidence and mechanisms of aneuploidy 175 
and mosaicism are extensively reviewed elsewhere [16] and therefore this review will not cover this 176 
topic in detail. Briefly however, the term mosaicism can be defined as the presence of two or more 177 
cell populations with different chromosome constitutions in a single embryo. Mosaicism can be 178 
“general” (proportions of aneuploid and euploid embryos are roughly equal in each lineage) or 179 
“confined” (where one karyotype predominates in each germ layer e.g. the trophectoderm). Several 180 
different mechanisms can lead to mosaicism including: anaphase lag, endoreplication and 181 
nondisjunction [17]. Anaphase lag manifests as the impediment of movement during anaphase of 182 
one homologous chromosome (meiosis) or one chromatid (mitosis) resulting in failure of connection 183 
to cellular spindle apparatus, or slow movement towards the pole of the cell and thus the ‘lagging’ 184 
chromosome is not integrated in the nucleus. Endoreplication describes a variation of the cell cycle 185 
that involves replication of the entire genome in the absence of cell division, leading to a polyploid 186 
cell; interestingly, evidence suggests that many cells in a diploid organism are polyploid [18]. 187 
Nondisjunction is the failure of homologous chromosomes to separate either in meiosis I, meiosis II 188 
(sister chromatid separation) or during mitosis. The existence of both monosomy and trisomy for the 189 
same chromosome in an embryo is indicative of nondisjunction as the predominant mechanism for 190 
embryo mosaicism. The literature suggests that anaphase lag is the predominant mechanism by 191 
which mosaicism occurs in preimplantation embryos [16]. Furthermore, mosaicism can be caused by 192 
any one of numerous factors albeit paternal, maternal or exogenous such as culture media or 193 
possibly controlled ovarian hyperstimulation during in vitro fertilization (IVF) [16]. Also noteworthy, 194 
is that embryo mosaicism can be classified into a number of categories, ranging from normal (all 195 
blastomeres being normal diploid), minor mosaic (more than 50% of nuclei are normal), major 196 
mosaic (more than 50% of nuclei are abnormal) and chaotic mosaicism (random segregation of 197 
chromosomes) [19]. It is thought that chaotic mosaicism arises due to chromosome loss and gains 198 
through no specific mechanism, characterised by nuclei depicting randomly different chromosome 199 
complements. A final, and perhaps most important, consideration is whether the embryos was 200 
euploid or aneuploid from the outset. Mosaics that were originally aneuploid tend to have the 201 
majority of cells with the same abnormality. Those that were euploid from the outset however tend 202 
to acquire abnormalities that may or may not have subsequent clinical relevance. The issue of 203 
mosaicism is still one that is vexing practitioners of PGS and, although FISH (even 24 chromosome 204 
FISH) is no longer used for diagnostic purposes, it may still find a use for establishing the level of 205 
mosaicism in cleavage stage, morula and blastocyst embryos.  206 
 207 
Results to date  208 
A preliminary study assessing mosaicism in whole embryos from day 3 blastomeres that were not 209 
transferred, thus were surplus material to IVF was performed by Ioannou et al. using the above 24- 210 
FISH assay [38]. The type of mosaicism in that cohort of embryos (data shown in table 2) supported 211 
previous findings of diploid/aneuploidy being the predominant pattern [12, 17]. Munne et al.[39] 212 
suggest that this form of mosaicism originates in the first few cleavage divisions and persists due to 213 
failure of cell cycle checkpoint control during cleavage stage [40]. Another study by Fonseka et al., 214 
(unpublished) indicated that mosaic embryos demonstrated more of chaotic mosaicism pattern; this 215 
was in contrast to the study by Munné and colleagues who reported that aneuploid mosaicism was 216 
the most common type of mosaicism seen in preimplantation embryos [39]. Results have also 217 
demonstrated that morphologically poor embryos had higher rates of polyploidy and diploid 218 
mosaicism. These types of studies are now performed on cells from the blastocyst stage (since this is 219 
now the preferred biopsy stage, used by the novel genome wide platforms) and allow the evaluation 220 
of the level of mosaicism [8] and types of aneuploidy. Our initial results, albeit on embryos we knew 221 
to be aneuploid, indicated patterns of mosaicism more complex that previously appreciated.  222 
In a second round of experiments, we extended the study further on a larger number of embryos, 223 
some for the same patient. In these set of experiments we looked at a larger number of embryos, 224 
some from the same patient. Figure 3 shows example images on each of the embryos and table 3 225 
summarises the results. 226 
Taken together, our results suggest that 24 chromosome FISH has great potential in unravelling the 227 
mysteries of chromosome mosaicism, one of the most hotly debated topics currently in 228 
preimplantation genetics. The ability to assay every chromosome on a cell by cell basis is particularly 229 
attractive. Our results suggest that embryo aneuploidy is not highly significantly correlated to 230 
maternal age, probably due, in part, to the large preponderance of post-zygotic (mitotic) errors. Of 231 
these, chromosome loss is the most common (presumably due to anaphase lag), followed by 232 
chromosome gain (endoreplication) whereas 3:1 mitotic non-disjunction of chromosomes appears 233 
to be rare in human preimplantation development.  234 
 235 
Nuclear Organisation 236 
 Another feature, with a more research oriented scope that the 24-FISH platform can provide is the 237 
simultaneous assessment of the nuclear organization in preimplantation embryos. The term nuclear 238 
organisation or “nuclear architecture” describes the spatial and temporal topology of chromosomes 239 
or sub-chromosomal compartments (e.g. genes) within the nucleus that forms a fully functional 240 
nuclear landscape. With the popularisation of FISH in the early 1990s allowing visualisation of 241 
chromosomes in the interphase nucleus came a flurry of studies that sought to address chromosome 242 
position in situ. These led to the realisation of the now widely accepted concept that, within the 243 
nucleus, chromosomes are not randomly distributed but are organised into discrete regions known 244 
as chromosome territories (CTs) [41-45]. Between these chromosome territories, inter-chromatin 245 
compartments containing macromolecular complexes are positioned. These are required for DNA 246 
replication, transcription, gene splicing and DNA repair and as such, the location of a chromosome 247 
within the nuclear volume is directly related to its accessibility to nuclear machinery [41] . The strict 248 
order of chromosome territories is believed to play a vital role in the regulation of gene expression, 249 
DNA replication, damage, and repair, controlling all cellular functions and development [41, 46-53].  250 
Evidence to support the hypothesis for a link between position and function is provided from studies 251 
of cellular differentiation processes. Examples include the repositioning of the immunoglobulin gene 252 
cluster, the Mash1 locus during neural induction [54] [55] the HoxB1 gene in mouse embryos [56], 253 
the repositioning of adipogenesis genes during porcine mesenchymal stem cell adipogenesis [57] 254 
and sex chromosome movement during porcine spermatogenesis  [58] just to name a few. In 255 
addition evidence supports that perturbation of nuclear organisation is correlated with certain 256 
diseases like laminopathies [59, 60] and certain cancers (promyelotic leukaemia, breast) [61]. 257 
Because of observations in different cell types and organisms [62, 63] proximity patterns of 258 
chromosomes, were identified leading to the proposal of two models (gene density and 259 
chromosome size) for the radial arrangement of CTs. 260 
 261 
The gene density model for nuclear organization postulates that gene rich chromosomes occupy 262 
more central regions of the nuclear volume whereas gene poor chromosomes are localized toward 263 
the periphery [64-70]. This model originated from observations in proliferating lymphoblasts and 264 
fibroblasts and can be seen in primates, old world monkeys, rodents, birds (excluding chicken) and 265 
cattle. The chromosome size model of nuclear organization originated from observations in flat 266 
ellipsoid fibroblasts, quiescent, and senescent cells. In this scenario smaller chromosomes are 267 
positioned towards the nuclear interior and larger chromosomes toward the outermost regions of 268 
the nuclear membrane [71-73]. Furthermore, the chromocentric model (seen in human sperm) 269 
where chromosomes are positioned with their centromeres toward the interior of the nucleus 270 
(forming chromocentres) and their telomeres extending toward the nuclear periphery forming 271 
dimers and tetramers [74-77]. 272 
 273 
Other models proposed later, included the chromosome territory interchromatin compartment (CT-274 
IC) model, which described the existence of two domains in the nuclei called chromosome territories 275 
(CT) and interchromatin compartments (IC) [78] the lattice model, which suggested that fibres from 276 
different chromosomes were able to intermingle to a certain extent at the edges of CTs [79] and 277 
finally, the interchromatin network (ICN) model, which explained the long range intermingling of 278 
distal chromosome regions belonging to the same chromosome, or between regions of different 279 
chromosomes via the ‘looping out’ of chromatin within and between chromosome territories 280 
respectively [48].  281 
 282 
Although there are many studies that have addressed nuclear organisation in a range of cell types 283 
from a wide spectrum of species, few studies have investigated nuclear organisation in the human 284 
embryo, and only one study has assessed the positioning of all 24 chromosomes [38]. Moreover, 285 
evidence presented thus far is not clear-cut. In studies that have assessed the nuclear positions of a 286 
subset of chromosomes (13, 16, 18, 21, 22, X and Y) in cleavage stage embryos (day 3-4), Mackenzie 287 
et al. [80] found central positioning of chromosomes 13, 18, 21 and X and peripheral positioning of 288 
chromosomes 16, 22 and Y, whereas both studies from Diblik  [81] and Finch [82] found a random 289 
distribution of these chromosomes (with the exception of chromosome 18, that showed a central 290 
localisation [81]). The reason behind the discrepancies observed could be due to number of factors, 291 
both technical (e.g. method of fixation and method of position analysis), or biological (e.g. the 292 
quality of the embryos used, which in any study akin to these, were likely deemed unsuitable for 293 
transfer due to developmental, morphological or genetic abnormalities). Nonetheless, despite these 294 
differences, there is clear evidence to suggest that nuclear organisation of totipotent cells 295 
originating from the cleavage stage preimplantation human embryo differs significantly to that of 296 
committed cell lines [38, 82], suggesting a functional role for chromosome positioning during 297 
development and differentiation. Furthermore, there is evidence to suggest that although 298 
chromosome positioning remains unperturbed in embryos with poor morphology compared to 299 
those of higher morphological grade, nuclear organisation is significantly altered in embryos with 300 
chromosome copy number abnormalities [80-82]. The biological mechanism behind this 301 
phenomenon remains as yet rather elusive, as shown by the fact that the nature and extent of re-302 
organisation in aneuploid blastomeres is not consistent among the literature. While MacKenzie et al. 303 
[80] report that an extra copy of a specific chromosome results in re-distribution from central to 304 
peripheral regions of the nucleus, the study from Finch et al. [82] reports that euploid blastomeres 305 
adopt a relaxed state of nuclear organisation in which chromosomes were positioned randomly and 306 
that aneuploidy was  associated with central positioning of chromosomes [80, 82]. The study from 307 
the Diblik group on the other hand, identified that of the chromosomes assessed, only chromosome 308 
18 showed differential positioning in blastomeres possessing an extra copy, and that this difference 309 
was characterised by a shift from a random to a peripheral location [81]. It is noteworthy however, 310 
that Finch et al. [82] highlight the difficulty in extrapolating conclusions regarding the shift of specific 311 
chromosomes in relation to an extra copy (of the same chromosome), given the small subset of 312 
chromosomes assayed and any additional chromosomal abnormalities in chromosomes that were 313 
not investigated.  314 
 315 
Assessing nuclear organization of human embryos by 24 chromosome FISH 316 
With the introduction of 24-colour FISH, the aforementioned shortfall could be addressed and 317 
previous observations could be expanded upon with the inclusion of the topology for each 318 
chromosome in the karyotype [38]. In order to measure nuclear organization we extrapolated 3D 319 
data from 2D preparations thus: For each probe, the question was asked whether a non-random 320 
pattern of distribution of the FISH signal could be identified in each embryo. If so, we asked which 321 
part of the nucleus was preferentially occupied with reference to five “shells,” each representing 322 
equal portions of the nucleus (from interior to periphery). We employed an ImageJ “macro” that 323 
divided each image of a nucleus into separate RGB planes (red and green for two of the six signals, 324 
blue for the DAPI counterstain) and then converted the blue image to a binary mask from which 5 325 
concentric regions of interest (shells) of equal area were created. The proportion of signal in each 326 
channel contained within each shell was measured relative to the total signal for that channel within 327 
the area covered by the binary mask. The output of these results was pasted to an Excel spreadsheet 328 
for statistical analysis. To compensate for the fact that we were deriving 3D information from a 329 
flattened 2D object, the proportion of signal within each shell was normalised against the DAPI 330 
density measured within that shell as a function of the amount of DNA measured. The results are 331 
represented as a histogram and a χ2 “goodness of fit” test was performed to test whether the 332 
nuclear position of the signal was non-randomly distributed to a specific shell (p<0.05) or “not 333 
discernible from a random pattern” (NDRP).  334 
 335 
As shown in table 4, by and large, our results showed that, human embryos at the morula or 336 
blastocyst stage (day 4 or 5 respectively) appear to adopt a chromocentric pattern of nuclear 337 
organisation, with almost all centromeric signals residing in the inner-most regions of the nuclear 338 
volume (with the exception of chromosome 5 predominantly identified at the nuclear periphery and 339 
chromosome 19, which showed a random distribution) [38]. This was an interesting finding that was 340 
consistent with results from studies in embryos from mice [83]. However the chromocentric 341 
arrangement seen in mice embryos appears to be consistent throughout development [83], whereas 342 
evidence for this in human embryos is partial from cleavage stage data, where 3 out of the 8 343 
chromosomes investigated had a peripheral distribution [80]. Since nuclear organisation is subjected 344 
to alteration during the process of differentiation in other cell types [58, 63, 84-93], it is possible that 345 
earlier findings from a small number of chromosomes assessed in cleavage stage embryos indicate a 346 
more fluid nature of nuclear organisation in totipotent blastomeres. At the blastocyst stage 347 
however, which is the earliest differentiation event, a more ordered organisation with spatial and 348 
temporal cues important for embryo development appears. Supporting this evidence is the fact that 349 
committed cells (e.g., lymphocytes) adopt a different pattern of organization compared to embryos 350 
(assessed on day 3 or 5 post fertilisation), as shown in table 4 [38]. In the future it would be 351 
interesting to compare the organisation by following an embryo (surplus to IVF) from blastomere to 352 
blastocyst stage, but more importantly apply this technique into a larger number of cells from 353 
blastocyst stage and stratify any organisation data based on the indication for IVF (e.g. AMA, RIF). 354 
 355 
In terms of the organisation of preimplantation embryos and aneuploidy status, our results have not 356 
revealed a difference between the individual cells (from the whole embryo) that were classified as 357 
“normal” for the needs of the study compared to the aneuploid ones. A partial explanation for this 358 
could be either due to the probes used, that targeted a predominantly heterochromatic proportion 359 
of the chromosome, small in size and therefore difficult to observe a potential noticeable difference 360 
using it as a single reference point, or more importantly the fact that the single cells assessed from 361 
the whole embryo, originated from unsuitable for transfer blastocysts that were probably already 362 
compromised in terms of their developmental potential. 363 
 364 
The use of different probes (e.g. whole chromosome territories or a combination of reference points 365 
on the chromosome) and if applicable better quality blastocysts could help to address the issues 366 
regarding ploidy and genome organisation when the whole karyotype is investigated with 24 colour 367 
FISH. 368 
 369 
Furthermore, a better appreciation about the organisation of preimplantation embryos will be 370 
possible by moving from 2D to 3D and the development of a more automated protocol that will 371 
allow to render the captured images into 3D models. Software like that is currently available. 372 
Currently, all studies that have assessed nuclear organisation in the blastomeres of human embryos 373 
have utilised 2D analysis techniques using centromere specific probes. The use of whole 374 
chromosome paints, combined with 3D analysis will provide a more complete map about the 375 
topology of chromosomes and how this might be related to the development of the human 376 
preimplantation embryo. 377 
Conclusion  378 
In conclusion, it seems that, while FISH is mostly “dead and buried” for the mainstream use in PGS, it 379 
still has a place for the assessment of mosaicism and for the study of nuclear organization. The 380 
development of a 24 chromosome protocol extends the power of this analysis and we would like to 381 
hope that it will still find an application as a result.  382 
 383 
 384 
 385 
386 
 387 
REFERENCES 388 
1. Handyside AH, Kontogianni EH, Hardy K, Winston RM: Pregnancies from biopsied human 389 
preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990, 344:768-390 
770. 391 
2. Griffin DK, Wilton LJ, Handyside AH, Atkinson GH, Winston RM, Delhanty JD: Diagnosis of sex 392 
in preimplantation embryos by fluorescent in situ hybridisation. Bmj 1993, 306:1382. 393 
3. Fiorentino F, Bono S, Biricik A, Nuccitelli A, Cotroneo E, Cottone G, Kokocinski F, Michel CE, 394 
Minasi MG, Greco E: Application of next-generation sequencing technology for 395 
comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic 396 
screening cycles. Human Reproduction 2014, 29:2802-2813. 397 
4. Munne S, Fragouli E, Colls P, Katz-Jaffe MG, W.B. S, Wells D: Improved detection of 398 
aneuploid blastocysts using a new 12-chromosome FISH test. Reproductive Biomedicine 399 
Online 2010, 20. 400 
5. Ioannou D, Meershoek EJ, Thornhill AR, Ellis M, Griffin DK: Multicolour interphase 401 
cytogenetics: 24 chromosome probes, 6 colours, 4 layers. Mol Cell Probes 2011. 402 
6. Skinner BM: Comparative cytogenomics between chicken and duck: wider insights into 403 
genome evolution and organisation. University of Kent, Biosciences; 2009. 404 
7. Ioannou D, Meershoek EJ, Christopikou D, Ellis M, Thornhill AR, Griffin DK: Nuclear 405 
organisation of sperm remains remarkably unaffected in the presence of defective 406 
spermatogenesis. Chromosome Res 2011, 19:741-753. 407 
8. Vera-Rodriguez M, Michel CE, Mercader A, Bladon AJ, Rodrigo L, Kokocinski F, Mateu E, Al-408 
Asmar N, Blesa D, Simon C, Rubio C: Distribution patterns of segmental aneuploidies in 409 
human blastocysts identified by next-generation sequencing. Fertil Steril 2016. 410 
9. Hassold T, Hunt P: To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev 411 
Genet 2001, 2:280-291. 412 
10. Martin RH: Meiotic errors in human oogenesis and spermatogenesis. Reprod Biomed Online 413 
2008, 16:523-531. 414 
11. Donoso P, Staessen C, Fauser BC, Devroey P: Current value of preimplantation genetic 415 
aneuploidy screening in IVF. Hum Reprod Update 2007, 13:15-25. 416 
12. Daphnis DD, Fragouli E, Economou K, Jerkovic S, Craft IL, Delhanty JD, Harper JC: Analysis of 417 
the evolution of chromosome abnormalities in human embryos from Day 3 to 5 using CGH 418 
and FISH. Mol Hum Reprod 2008, 14:117-125. 419 
13. Delhanty JD: Mechanisms of aneuploidy induction in human oogenesis and early 420 
embryogenesis. Cytogenet Genome Res 2005, 111:237-244. 421 
14. Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, 422 
Vikkula M, Schuit F, et al: Chromosome instability is common in human cleavage-stage 423 
embryos. Nat Med 2009, 15:577-583. 424 
15. Fragouli E, Alfarawati S, Goodall NN, Sanchez-Garcia JF, Colls P, Wells D: The cytogenetics of 425 
polar bodies: insights into female meiosis and the diagnosis of aneuploidy. Mol Hum 426 
Reprod 2011. 427 
16. Taylor TH, Gitlin SA, Patrick JL, Crain JL, Wilson JM, Griffin DK: The origin, mechanisms, 428 
incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod 429 
Update 2014. 430 
17. Daphnis DD, Delhanty JD, Jerkovic S, Geyer J, Craft I, Harper JC: Detailed FISH analysis of day 431 
5 human embryos reveals the mechanisms leading to mosaic aneuploidy. Hum Reprod 432 
2005, 20:129-137. 433 
18. Lee HO, Davidson JM, Duronio RJ: Endoreplication: polyploidy with purpose. Genes Dev 434 
2009, 23:2461-2477. 435 
19. Delhanty JD, Harper JC, Ao A, Handyside AH, Winston RM: Multicolour FISH detects 436 
frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos 437 
from fertile patients. Hum Genet 1997, 99:755-760. 438 
20. Griffin DK, Fonseka G, Tempest HG, Thornhill AR, Ioannou D: Interphase Cytogenetics at the 439 
Earliest Stages of Human Development. In Human Interphase Chromosomes: Biomedical 440 
Aspects. Edited by Yurov BY, Vorsanova GS, Iourov YI. New York, NY: Springer New York; 441 
2013: 123-138 442 
21. Hassold T, Hunt P: Maternal age and chromosomally abnormal pregnancies: what we know 443 
and what we wish we knew. Curr Opin Pediatr 2009, 21:703-708. 444 
22. Munne S, Dailey T, Sultan KM, Grifo J, Cohen J: The Use of First Polar Bodies for 445 
Preimplantation Diagnosis of Aneuploidy. Human Reproduction 1995, 10:1014-1020. 446 
23. Verlinsky Y, Cieslak J, Freidine M, Ivakhnenko V, Wolf G, Kovalinskaya L, White M, Lifchez A, 447 
Kaplan B, Moise J, et al: Pregnancies Following Pre-Conception Diagnosis of Common 448 
Aneuploidies by Fluorescent in-Situ Hybridization. Human Reproduction 1995, 10:1923-449 
1927. 450 
24. Harton GL, Harper JC, Coonen E, Pehlivan T, Vesela K, Wilton L: ESHRE PGD consortium best 451 
practice guidelines for fluorescence in situ hybridization-based PGD. Hum Reprod 2010. 452 
25. Munne S: Preimplantation genetic diagnosis and human implantation--a review. Placenta 453 
2003, 24 Suppl B:S70-76. 454 
26. Harper J, Sermon K, Geraedts J, Vesela K, Harton G, Thornhill A, Pehlivan T, Fiorentino F, 455 
SenGupta S, de Die-Smulders C, et al: What next for preimplantation genetic screening? 456 
Hum Reprod 2008, 23:478-480. 457 
27. Harper J, Coonen E, De Rycke M, Fiorentino F, Geraedts J, Goossens V, Harton G, Moutou C, 458 
Pehlivan Budak T, Renwick P, et al: What next for preimplantation genetic screening (PGS)? 459 
A position statement from the ESHRE PGD Consortium steering committee. Hum Reprod 460 
2010. 461 
28. Jansen RP, Bowman MC, de Boer KA, Leigh DA, Lieberman DB, McArthur SJ: What next for 462 
preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for 463 
aneuploidy. Hum Reprod 2008, 23:1476-1478. 464 
29. Mastenbroek S, Scriven P, Twisk M, Viville S, Van der Veen F, Repping S: What next for 465 
preimplantation genetic screening? More randomized controlled trials needed? Hum 466 
Reprod 2008. 467 
30. Yang ZH, Liu JE, Collins GS, Salem SA, Liu XH, Lyle SS, Peck AC, Sills ES, Salem RD: Selection of 468 
single blastocysts for fresh transfer via standard morphology assessment alone and with 469 
array CGH for good prognosis IVF patients: results from a randomized pilot study. 470 
Molecular Cytogenetics 2012, 5. 471 
31. Scott RT, Upham KM, Forman EJ, Zhao T, Treff NR: Cleavage-stage biopsy significantly 472 
impairs human embryonic implantation potential while blastocyst biopsy does not: a 473 
randomized and paired clinical trial. Fertility and Sterility 2013, 100:624-630. 474 
32. Beyer CE, Osianlis T, Boekel K, Osborne E, Rombauts L, Catt J, Kralevski V, Aali BS, Gras L: 475 
Preimplantation genetic screening outcomes are associated with culture conditions. Hum 476 
Reprod 2009. 477 
33. Rezazadeh Valojerdi M, Eftekhari-Yazdi P, Karimian L, Hassani F, Movaghar B: Vitrification 478 
versus slow freezing gives excellent survival, post warming embryo morphology and 479 
pregnancy outcomes for human cleaved embryos. J Assist Reprod Genet 2009. 480 
34. Zhang X, Trokoudes KM, Pavlides C: Vitrification of biopsied embryos at cleavage, morula 481 
and blastocyst stage. Reprod Biomed Online 2009, 19:526-531. 482 
35. Baart EB, van den Berg I, Martini E, Eussen HJ, Fauser BC, Van Opstal D: FISH analysis of 15 483 
chromosomes in human day 4 and 5 preimplantation embryos: the added value of 484 
extended aneuploidy detection. Prenat Diagn 2007, 27:55-63. 485 
36. Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, Moutou C, 486 
Robinson MD, Schmutzler AG, Scriven PN, et al: ESHRE PGD Consortium 'Best practice 487 
guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation 488 
genetic screening (PGS)'. Hum Reprod 2005, 20:35-48. 489 
37. Colls P, Goodall N, Zheng X, Munne S: Increased efficiency of preimplantation genetic 490 
diagnosis for aneuploidy by testing 12 chromosomes. RBM Online 2009, 19:532-538. 491 
38. Ioannou D, Fonseka KG, Meershoek EJ, Thornhill AR, Abogrein A, Ellis M, Griffin DK: Twenty-492 
four chromosome FISH in human IVF embryos reveals patterns of post-zygotic 493 
chromosome segregation and nuclear organisation. Chromosome Res 2012, 20:447-460. 494 
39. Munne S, Weier HU, Grifo J, Cohen J: Chromosome mosaicism in human embryos. Biol 495 
Reprod 1994, 51:373-379. 496 
40. Delhanty JD, Handyside AH: The origin of genetic defects in the human and their detection 497 
in the preimplantation embryo. Hum Reprod Update 1995, 1:201-215. 498 
41. Cremer T, Cremer C: Chromosome territories, nuclear architecture and gene regulation in 499 
mammalian cells. Nat Rev Genet 2001, 2:292-301. 500 
42. Manuelidis L: A view of interphase chromosomes. Science 1990, 250:1533-1540. 501 
43. Meaburn KJ, Misteli T: Cell biology: chromosome territories. Nature 2007, 445:379-781. 502 
44. Misteli T: Concepts in nuclear architecture. Bioessays 2005, 27:477-487. 503 
45. Parada L, Misteli T: Chromosome positioning in the interphase nucleus. Trends Cell Biol 504 
2002, 12:425-432. 505 
46. Dundr M, Misteli T: Biogenesis of Nuclear Bodies. Cold Spring Harbor Perspectives in Biology 506 
2010, 2:a000711. 507 
47. Foster HA, Bridger JM: The genome and the nucleus: a marriage made by evolution. 508 
Genome organisation and nuclear architecture. Chromosoma 2005, 114:212-229. 509 
48. Branco MR, Pombo A: Chromosome organization: new facts, new models. Trends Cell Biol 510 
2007, 17:127-134. 511 
49. Pederson T: The spatial organization of the genome in mammalian cells. Curr Opin Genet 512 
Dev 2004, 14:203-209. 513 
50. Rouquette J, Genoud C, Vazquez-Nin GH, Kraus B, Cremer T, Fakan S: Revealing the high-514 
resolution three-dimensional network of chromatin and interchromatin space: A novel 515 
electron-microscopic approach to reconstructing nuclear architecture. Chromosome 516 
Research 2009, 17:801-810. 517 
51. Rajapakse I, Groudine M: On emerging nuclear order. Journal of Cell Biology 2011, 192:711-518 
721. 519 
52. Schoenfelder S, Clay I, Fraser P: The transcriptional interactome: gene expression in 3D. 520 
Current Opinion in Genetics & Development 2010, 20:127-133. 521 
53. Spector DL, Lamond AI: Nuclear Speckles. Cold Spring Harbor Perspectives in Biology 2011, 3. 522 
54. Schneider R, Grosschedl R: Dynamics and interplay of nuclear architecture, genome 523 
organization, and gene expression. Genes Dev 2007, 21:3027-3043. 524 
55. Ioannou D, Kandukuri L, Quadri A, Becerra V, Simpson JL, Tempest HG: Spatial positioning of 525 
all 24 chromosomes in the lymphocytes of six subjects: evidence of reproducible 526 
positioning and spatial repositioning following DNA damage with hydrogen peroxide and 527 
ultraviolet B. PLoS One 2015, 10:e0118886. 528 
56. Takizawa T, Meaburn KJ, Misteli T: The meaning of gene positioning. Cell 2008, 135:9-13. 529 
57. Szczerbal I, Foster HA, Bridger JM: The spatial repositioning of adipogenesis genes is 530 
correlated with their expression status in a porcine mesenchymal stem cell adipogenesis 531 
model system. Chromosoma 2009, 118:647-663. 532 
58. Foster HA, Abeydeera LR, Griffin DK, Bridger JM: Non-random chromosome positioning in 533 
mammalian sperm nuclei, with migration of the sex chromosomes during late 534 
spermatogenesis. J Cell Sci 2005, 118:1811-1820. 535 
59. Bridger JM, Arican-Gotkas HD, Foster HA, Godwin LS, Harvey A, Kill IR, Knight M, Mehta IS, 536 
Ahmed MH: The Non-random Repositioning of Whole Chromosomes and Individual Gene 537 
Loci in Interphase Nuclei and Its Relevance in Disease, Infection, Aging, and Cancer. Adv 538 
Exp Med Biol 2014, 773:263-279. 539 
60. Mewborn SK, Puckelwartz MJ, Abuisneineh F, Fahrenbach JP, Zhang Y, MacLeod H, Dellefave 540 
L, Pytel P, Selig S, Labno CM, et al: Altered chromosomal positioning, compaction, and gene 541 
expression with a lamin A/C gene mutation. PLoS One 2010, 5:e14342. 542 
61. Marella NV, Bhattacharya S, Mukherjee L, Xu J, Berezney R: Cell type specific chromosome 543 
territory organization in the interphase nucleus of normal and cancer cells. J Cell Physiol 544 
2009, 221:130-138. 545 
62. Funabiki H, Hagan I, Uzawa S, Yanagida M: Cell Cycle-Dependent Specific Positioning and 546 
Clustering of Centromeres and Telomeres in Fission Yeast. Journal of Cell Biology 1993, 547 
121:961-976. 548 
63. Mayer R, Brero A, von Hase J, Schroeder T, Cremer T, Dietzel S: Common themes and cell 549 
type specific variations of higher order chromatin arrangements in the mouse. BMC Cell 550 
Biol 2005, 6:44. 551 
64. Cremer M, Kupper K, Wagler B, Wizelman L, von Hase J, Weiland Y, Kreja L, Diebold J, 552 
Speicher MR, Cremer T: Inheritance of gene density-related higher order chromatin 553 
arrangements in normal and tumor cell nuclei. J Cell Biol 2003, 162:809-820. 554 
65. Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA: Differences in the 555 
localization and morphology of chromosomes in the human nucleus. J Cell Biol 1999, 556 
145:1119-1131. 557 
66. Boyle S, Gilchrist S, Bridger JM, Mahy NL, Ellis JA, Bickmore WA: The spatial organization of 558 
human chromosomes within the nuclei of normal and emerin-mutant cells. Hum Mol 559 
Genet 2001, 10:211-219. 560 
67. Lukasova E, Kozubek S, Kozubek M, Falk M, Amrichova J: The 3D structure of human 561 
chromosomes in cell nuclei. Chromosome Res 2002, 10:535-548. 562 
68. Federico C, Cantarella CD, Di Mare P, Tosi S, Saccone S: The radial arrangement of the 563 
human chromosome 7 in the lymphocyte cell nucleus is associated with chromosomal 564 
band gene density. Chromosoma 2008, 117:399-410. 565 
69. Tanabe H, Habermann FA, Solovei I, Cremer M, Cremer T: Non-random radial arrangements 566 
of interphase chromosome territories: evolutionary considerations and functional 567 
implications. Mutat Res 2002, 504:37-45. 568 
70. Tanabe H, Kupper K, Ishida T, Neusser M, Mizusawa H: Inter- and intra-specific gene-569 
density-correlated radial chromosome territory arrangements are conserved in Old World 570 
monkeys. Cytogenet Genome Res 2005, 108:255-261. 571 
71. Sun HB, Shen J, Yokota H: Size-dependent positioning of human chromosomes in 572 
interphase nuclei. Biophys J 2000, 79:184-190. 573 
72. Bolzer A, Kreth G, Solovei I, Koehler D, Saracoglu K, Fauth C, Muller S, Eils R, Cremer C, 574 
Speicher MR, Cremer T: Three-dimensional maps of all chromosomes in human male 575 
fibroblast nuclei and prometaphase rosettes. PLoS Biol 2005, 3:e157. 576 
73. Habermann FA, Cremer M, Walter J, Kreth G, von Hase J, Bauer K, Wienberg J, Cremer C, 577 
Cremer T, Solovei I: Arrangements of macro- and microchromosomes in chicken cells. 578 
Chromosome Res 2001, 9:569-584. 579 
74. Solov'eva L, Svetlova M, Bodinski D, Zalensky AO: Nature of telomere dimers and 580 
chromosome looping in human spermatozoa. Chromosome Res 2004, 12:817-823. 581 
75. Zalenskaya IA, Bradbury EM, Zalensky AO: Chromatin structure of telomere domain in 582 
human sperm. Biochem Biophys Res Commun 2000, 279:213-218. 583 
76. Zalenskaya IA, Zalensky AO: Non-random positioning of chromosomes in human sperm 584 
nuclei. Chromosome Res 2004, 12:163-173. 585 
77. Zalensky AO, Allen MJ, Kobayashi A, Zalenskaya IA, Balhorn R, Bradbury EM: Well-defined 586 
genome architecture in the human sperm nucleus. Chromosoma 1995, 103:577-590. 587 
78. Lichter JB, Difilippantonio MJ, Pakstis AJ, Goodfellow PJ, Ward DC, Kidd KK: Physical and 588 
genetic maps for chromosome 10. Genomics 1993, 16:320-324. 589 
79. Dehghani H, Dellaire G, Bazett-Jones DP: Organization of chromatin in the interphase 590 
mammalian cell. Micron 2005, 36:95-108. 591 
80. McKenzie LJ, Carson SA, Marcelli S, Rooney E, Cisneros P, Torskey S, Buster J, Simpson JL, 592 
Bischoff FZ: Nuclear chromosomal localization in human preimplantation embryos: 593 
correlation with aneuploidy and embryo morphology. Hum Reprod 2004, 19:2231-2237. 594 
81. Diblik J, Macek M, Sr., Magli MC, Krejci R, Gianaroli L: Chromosome topology in normal and 595 
aneuploid blastomeres from human embryos. Prenat Diagn 2007, 27:1091-1099. 596 
82. Finch KA, Fonseka G, Ioannou D, Hickson N, Barclay Z, Chatzimeletiou K, Mantzouratou A, 597 
Handyside A, Delhanty J, Griffin DK: Nuclear organisation in totipotent human nuclei and its 598 
relationship to chromosomal abnormality. J Cell Sci 2008, 121:655-663. 599 
83. Martin C, Beaujean N, Brochard V, Audouard C, Zink D, Debey P: Genome restructuring in 600 
mouse embryos during reprogramming and early development. Dev Biol 2006, 292:317-601 
332. 602 
84. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG: Association of 603 
transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 604 
1997, 91:845-854. 605 
85. Chambeyron S, Bickmore WA: Chromatin decondensation and nuclear reorganization of 606 
the HoxB locus upon induction of transcription. Genes & Development 2004, 18:1119-1130. 607 
86. Kuroda M, Tanabe H, Yoshida K, Oikawa K, Saito A, Kiyuna T, Mizusawa H, Mukai K: 608 
Alteration of chromosome positioning during adipocyte differentiation. J Cell Sci 2004, 609 
117:5897-5903. 610 
87. Galiova G, Bartova E, Kozubek S: Nuclear topography of beta-like globin gene cluster in IL-3-611 
stimulated human leukemic K-562 cells. Blood Cells Molecules and Diseases 2004, 33:4-14. 612 
88. Parada LA, McQueen PG, Misteli T: Tissue-specific spatial organization of genomes. Genome 613 
Biol 2004, 5:R44. 614 
89. Bartova E, Harnicarova A, Pachernik J, Kozubek S: Nuclear topography and expression of the 615 
BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA 616 
interference. Leukemia Research 2005, 29:901-913. 617 
90. Kim SH, McQueen PG, Lichtman MK, Shevach EM, Parada LA, Misteli T: Spatial genome 618 
organization during T-cell differentiation. Cytogenetic and Genome Research 2004, 619 
105:292-301. 620 
91. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fisher AG, Singh H: Subnuclear 621 
compartmentalization of immunoglobulin loci during lymphocyte development. Science 622 
2002, 296:158-162. 623 
92. Alcobia: Spatial associations of centromeres in the nuclei of hematopoietic cells: evidence 624 
for cell-type-specific organizational patterns (vol 95, pg 1608, 2000). Blood 2000, 96:987-625 
987. 626 
93. Hewitt SL, High FA, Reiner SL, Fisher AG, Merkenschlager M: Nuclear repositioning marks 627 
the selective exclusion of lineage-inappropriate transcription factor loci during T helper 628 
cell differentiation. European Journal of Immunology 2004, 34:3604-3613. 629 
 630 
631 
Multicolour detection of every chromosome as a means of detecting 
mosaicism and nuclear organisation in human embryonic nuclei 
 
Turner KJ,
1
* Fowler KE,
2
* Fonseka GL
1
, Griffin DK
1
 and Ioannou D
3 
1. School of Biosciences, University of Kent, Canterbury, Kent, UK 
2. School of Human and Life Sciences, Canterbury Christ Church University, Canterbury, UK 
3. Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, 
Florida International University, Miami, FL, USA. 
 
*Turner KJ and Fowler KE are joint first authors 
Griffin DK is the corresponding author 
 
 
 Introduction 
Fluorescence in situ Hybridisation (FISH) revolutionised the study of cytogenetics in the late 1980s, 
enabling basic scientists and clinicians to visualise specific chromosome regions within the nucleus. It 
provided, for the first time, a direct link between the microscope and DNA sequence. The technique 
uses fluorescently labelled short stretches of DNA (probes) that have a high level of sequence 
complementarity to specific sections of a chromosome. Following denaturation of chromosomal 
(target DNA) and probe, hybridisation is allowed to occur under specific conditions (e.g. 
temperature, concentration of formamide) to allow high affinity between target and probe DNA. By 
the early 1990s FISH was adopted by fertility centres worldwide as means of sex determination in 
preimplantation embryos from couples at risk of transmitting X-linked disorders [1, 2]. Shortly after, 
FISH found additional roles in the identification of unbalanced translocations and in chromosome 
copy number screening (e.g. embryo, sperm aneuploidy). Since then, the rapid increase in the use of 
in vitro fertilisation (IVF) and preimplantation genetic diagnosis (PGD) globally has not only enabled 
huge advancements in reproductive medicine, but has also provided a unique opportunity to study 
the cytogenetics of human embryos at the earliest stages of development. With the ultimate goal of 
developing diagnostic tests and improving patient care, those embryos produced by IVF cycles that 
are not deemed for transfer represent a valuable source of sample material under appropriate 
ethical justification. Nowadays, FISH has been replaced with newer technologies for the purposes of 
PGD using single cells; first by array CGH, then by single nucleotide polymorphism arrays (SNP) or 
quantitative real-time polymerase chain reaction (qRT-PCR) and most recently by next generation 
sequencing (NGS) [3]. Concurrently with the application of these newer technologies, the platform 
of evaluating the chromosomal status of preimplantation embryos has shifted from blastomere to 
trophectoderm biopsy (blastocyst stage). Despite the advancement in technologies, the cell-by-cell 
analysis of blastomeres or available blastocysts within an embryo with the new techniques is still 
prohibitively expensive. As a result, FISH remains very much an invaluable resource for the study of 
cytogenetics in preimplantation embryos in terms of evaluating the level of mosaicism and at a more 
research level the nuclear organisation of chromosomes at this early stage of development. The 
purpose of this review is to give an overview of the history of FISH in PGD/PGS, cover the reasons 
why it fell out of favour and indicate how it may, with recent adaptations, be used as a tool for 
research and “follow up” of clinical cases. 
 
A brief history of FISH and its use for PGS 
The assessment of chromosome copy number in preimplantation embryos is the essence of 
preimplantation genetic screening (PGS), a commonly elected procedure in couples where advanced 
maternal age (AMA), recurrent miscarriage, recurrent implantation failure (RIF) or male factor 
infertility is implicated. It is widely believed that aneuploidy (presence of an extra or missing 
chromosome) is present in approximately 0.6% of live newborn infants, 6% of stillbirths, and 60% of 
spontaneous abortions [9, 10]. Moreover, numerical chromosome abnormalities are present in 60-
70% of embryos generated by IVF (at the blastomere stage) [11-14], whereas it can reach levels of 
>50% in the blastocyst stage [15]. Although the majority of chromosome copy number abnormalities 
are lethal, aneuploidies involving a few specific chromosomes survive to term. On this basis, 
following a rise in the use of FISH for sex determination in the early 1990s and the availability of 
multicolour probes, the use of FISH was expanded to the detection of aneuploidy in order to 
selectively implant embryos more likely to be fully euploid.  
 
The rationale behind the use of PGS in infertile couples requiring assisted reproductive technology 
(ART), is to increase pregnancy rates, since morphology alone does not suffice to distinguish a 
euploid from an aneuploid embryo. Therefore, by transferring euploid embryos, the chances of a 
viable pregnancy should be higher. The logic of this hypothesis is generally accepted in the field of 
reproductive medicine and can have particular application in women of AMA, couples with RIF, 
repeated miscarriage or severe male factor infertility [20, 21]. Initially from the 1990s to 2010, FISH 
was used to perform diagnosis on the chromosomal complement of polar bodies and blastomeres 
[22, 23]. A total of eight chromosomes, six autosomal chromosomes (13, 15, 16, 18, 21 and 22) and 
the sex chromosomes were more commonly tested in IVF clinics through PGS as these were known 
to be involved in aneuploidies detected in spontaneous abortions and in trisomic live births [11, 24]. 
Despite the initial reports for an increase in implantation rates, reduction in trisomic offspring and 
spontaneous abortions [25, 26], criticism emerged since these reports were non-randomised, had 
poor experimental design, inadequate control groups and lack of report on live births [26]. 
 
From 2004 to 2010, eleven randomised control trials (RCTs) showed that PGS with FISH did not 
increase delivery rates, some studies showed the contrary and sparked a huge debate in the field. 
The reasons [26-29] for the reduced efficiency of PGS-FISH are beyond the scope of this review 
however they extended from technique-inherent limitations to biological (e.g. high levels of 
mosaicism in cleavage stage embryos, biopsy stage). This opened up different methodological 
approaches for the analysis of all chromosomes using genome wide platforms (e.g. aCGH, SNP-array, 
NGS), prompted multi-centre RCTS [30, 31] and parallel with improvements in culturing [32] and 
cryopreservation of embryos (e.g., vitrification) [33, 34] the diagnostic platform was shifted from day 
3 to day 5 (blastocysts), making at the same time FISH an outdated technology for the complete 
chromosomal complement analysis in a PGS setting.  
 
24 chromosome FISH on single cells  
During the time since FISH was first popularised, the technique has evolved considerably to see the 
development of directly labelled, multicolour, commercially available probes with shorter 
hybridisation times and greater hybridisation efficiencies, which has enabled the ability to study up 
to 12 chromosomes within the same nucleus at once [4]. Better still, whole chromosome paints for 
all 24 chromosomes soon became commercially available by mixing fluorochromes to produce 
secondary colours. However, the difficulty with taking this approach is that overlapping signals in the 
interphase nucleus are not easily distinguishable from one another. To circumvent this problem 
therefore, we developed a new ‘multilayer’ approach to 24-chromosome FISH, enabling 
comprehensive analysis of copy number for each chromosome in the karyotype. Based on a 
previously published protocol termed ‘re-FISH’, six spectrally distinct probes were used, in four 
consecutive rounds of FISH to visualise all 24 chromosomes [5]. The setup of 6 fluorochromes and 4 
rounds of hybridization was selected to maximise the outcome of chromosome copy number, while 
reducing the rounds of re-probing of nuclei and thus increase the chances of signal efficiency. In 
addition the probes for the chromosomes that constitute each round of hybridisation were 
categorised based on availability of centromeric sequences for that particular chromosome or not.  
 The first three rounds of hybridisation (that can be inter-changeable) use probes against 
centromeric sequences; round one for chromosomes 1, 3, 4, 6, 7 and 8, round two for chromosomes 
9, 10, 11, 12, 17 and 20, round three for chromosomes 2, 15, 16, 18, X, Y whereas the fourth round 
uses unique sequence targets for 6 chromosomes that do not have unique centromeric probes, 
chromosomes 5, 13, 14, 19, 21 and 22. The protocol can be completed within 24 hours, since the 
hybridisation times for the centromeric layers is 15-30 minutes and overnight for the unique 
sequence layer, fitting in a clinical setting and tailored for different applications (e.g. embryo versus 
sperm aneuploidy). The fast hybridisation times for the centromeric layers are possible due to the 
highly repetitive sequences (α-satellite) used to generate the respective probes. 
 
 A bespoke capturing system is necessary in order to be able to image all fluorochromes in separate 
channels plus the DAPI counterstain in a different channel. In-house, we used a modified version of 
Digital Scientific’s SmartCapture, and this novel approach that has been previously validated in 
different cell types [5], offers a powerful research tool in the identification of chromosome copy 
number that can be applied to different cell types. It also allows for the simultaneous assessment of 
nuclear organisation; that is, the so-called “nuclear address” of chromosomes (or sub-chromosomal 
regions and/or loci) within the nucleus. For this feature a custom-script for Image J (freely-
downloadable software) is required and more details have been previously published here [6, 7]. 
The main advantage of this approach is the ability to assess the levels of mosaicism in individual cell 
populations, particularly early human preimplantation development. While cell-by-cell analysis is 
certainly technically feasible (and potentially more accurate) using array CGH or NGS, the costs 
involved are prohibitively expensive. Practical applications include the “follow up” validation of PGS 
cases and assessing the levels of mosaicism in cleavage stage, morula or blastocyst embryos. In the 
latter case, blastulation represents the first visible stage of differentiation of the human embryo and 
study of mosaicism at this stage is attracting great interest in the scientific literature at the moment 
[8].  
 
The methodology  
Material used for our studies have been mostly “follow up” aneuploid PGS cases, the collaborating 
clinics were the London Bridge Fertility Centre and the Lister Fertility Clinic. The protocol involves six 
Kreatech fluorochromes, namely PlatinumBright™: 405 (blue), 415 (light blue/aqua), 495 (green), 
547 (light red/orange), 590 (dark red), 647 (far red) plus the DAPI counterstain in a four-stage 
probing and re-probing strategy. All probes for this protocol were synthesized by Kreatech 
Diagnostics using the Universal Linkage Labeling System (KBI-40060): 
http://www.kreatech.com/rest/products/repeat-freetm-poseidontm-fish-dna-
probes/preimplantation-genetic-screening/multistar-24-fish.html, including six unique sequence 
targets for chromosomes 5, 13, 14, 19, 21 and 22 and the remaining 18 centromeric probes. These 
are shown in figures 1 and 2. The highly repetitive nature of the remaining unique centromeric 
targets meant that hybridisation times could be reduced to 15-30 minutes, however the unique 
sequence probes required overnight hybridisation. The choice of fluorochromes for each individual 
probe relied on combining the strongest signals with the least strong fluorochromes and vice versa. 
For instance chromosome 18 (one of the brightest and most reliable probes) was labelled with the 
blue (the least bright) fluorochrome. Table 1 illustrates the final probe-fluorochrome combinations. 
Human IVF embryo nuclei are fixed to slides by standard protocols; slides are washed in PBS for 2 
minutes and dehydrated and dried using an ethanol series. Pepsin treatment removes excess protein 
(1 mg/ml pepsin in 0.01 M HCl, 20 min at 37 °C), then the slides are rinsed in distilled water and PBS, 
followed by a paraformaldehyde (1% in PBS) fix at 4 °C for 10 min, followed by another PBS and 
distilled water wash and an ethanol dehydration and drying step. The four probe combinations are 
dissolved in hybridization mix (Kreatech standard protocols). It is important to pre-denature the 
probes at 73 °C for 10 min before application on the slide, then co-denaturation of probe and 
chromosomes proceeds at 75°C for 90 seconds in a “Thermobrite-StatSpin” before hybridization at 
37°C. The hybridization period for the first three (alpha, beta, gamma) rounds of hybridization 
(centromeric probes) is for 30 min, whereas for the final round (omega), it is overnight. Post-
hybridization washes are for 1 min 30 s in 0.7× SSC, 0.3%Tween 20 at 72 °C followed by a 2 min in 
2×SSC at room temperature. Slides are mounted in Vectashield containing 0.1 ng/μl of DAPI (Vector 
labs) before microscopy and image analysis. After analysis and image capture, slides are washed in 
2×SSC at room temperature to remove the coverslip and then washed for 30 seconds in distilled 
water (72°C) to remove the bound probe. An ethanol series precedes air-drying before continuation 
to the next round of hybridization. The protocol is the same for the second, third and final rounds 
with the following exceptions: The overnight hybridization time for the final round (previously 
mentioned), pepsin and paraformaldehyde treatment are only required for the first round; the post-
hybridization wash time is reduced with every round from 90 s (first round of hybridization) to 50–60 
s (second round) to 30 s (third and final rounds). Microscopy analysis, at least in our hands, is 
performed on an Olympus BX-61 epifluorescence microscope equipped with a cooled CCD camera 
(by Digital Scientific—Hamamatsu Orca-ER C4742-80) and using the appropriate filters. To enable 
analysis of the fluorochromes for image acquisition two communicating filter wheels (Digital 
Scientific UK) with the appropriate filters were used. The recommended filters by the probe 
manufacturers can be found here: http://www.kreatech.com/rest/customer-service-
support/technical-support/fluorophores-and-filter-recommendation.html and the image capture 
system was SmartCapture (Digital Scientific UK). 
 
Chromosome mosaicism in human preimplantation development  
Early studies that assessed chromosome copy number in IVF preimplantation embryos discovered 
that a large proportion of human embryos are mosaic. The incidence and mechanisms of aneuploidy 
and mosaicism are extensively reviewed elsewhere [16] and therefore this review will not cover this 
topic in detail. Briefly however, the term mosaicism can be defined as the presence of two or more 
cell populations with different chromosome constitutions in a single embryo. Mosaicism can be 
“general” (proportions of aneuploid and euploid embryos are roughly equal in each lineage) or 
“confined” (where one karyotype predominates in each germ layer e.g. the trophectoderm). Several 
different mechanisms can lead to mosaicism including: anaphase lag, endoreplication and 
nondisjunction [17]. Anaphase lag manifests as the impediment of movement during anaphase of 
one homologous chromosome (meiosis) or one chromatid (mitosis) resulting in failure of connection 
to cellular spindle apparatus, or slow movement towards the pole of the cell and thus the ‘lagging’ 
chromosome is not integrated in the nucleus. Endoreplication describes a variation of the cell cycle 
that involves replication of the entire genome in the absence of cell division, leading to a polyploid 
cell; interestingly, evidence suggests that many cells in a diploid organism are polyploid [18]. 
Nondisjunction is the failure of homologous chromosomes to separate either in meiosis I, meiosis II 
(sister chromatid separation) or during mitosis. The existence of both monosomy and trisomy for the 
same chromosome in an embryo is indicative of nondisjunction as the predominant mechanism for 
embryo mosaicism. The literature suggests that anaphase lag is the predominant mechanism by 
which mosaicism occurs in preimplantation embryos [16]. Furthermore, mosaicism can be caused by 
any one of numerous factors albeit paternal, maternal or exogenous such as culture media or 
possibly controlled ovarian hyperstimulation during in vitro fertilization (IVF) [16]. Also noteworthy, 
is that embryo mosaicism can be classified into a number of categories, ranging from normal (all 
blastomeres being normal diploid), minor mosaic (more than 50% of nuclei are normal), major 
mosaic (more than 50% of nuclei are abnormal) and chaotic mosaicism (random segregation of 
chromosomes) [19]. It is thought that chaotic mosaicism arises due to chromosome loss and gains 
through no specific mechanism, characterised by nuclei depicting randomly different chromosome 
complements. A final, and perhaps most important, consideration is whether the embryos was 
euploid or aneuploid from the outset. Mosaics that were originally aneuploid tend to have the 
majority of cells with the same abnormality. Those that were euploid from the outset however tend 
to acquire abnormalities that may or may not have subsequent clinical relevance. The issue of 
mosaicism is still one that is vexing practitioners of PGS and, although FISH (even 24 chromosome 
FISH) is no longer used for diagnostic purposes, it may still find a use for establishing the level of 
mosaicism in cleavage stage, morula and blastocyst embryos.  
 
Results to date  
A preliminary study assessing mosaicism in whole embryos from day 3 blastomeres that were not 
transferred, thus were surplus material to IVF was performed by Ioannou et al. using the above 24- 
FISH assay [38]. The type of mosaicism in that cohort of embryos (data shown in table 2) supported 
previous findings of diploid/aneuploidy being the predominant pattern [12, 17]. Munne et al.[39] 
suggest that this form of mosaicism originates in the first few cleavage divisions and persists due to 
failure of cell cycle checkpoint control during cleavage stage [40]. Another study by Fonseka et al., 
(unpublished) indicated that mosaic embryos demonstrated more of chaotic mosaicism pattern; this 
was in contrast to the study by Munné and colleagues who reported that aneuploid mosaicism was 
the most common type of mosaicism seen in preimplantation embryos [39]. Results have also 
demonstrated that morphologically poor embryos had higher rates of polyploidy and diploid 
mosaicism. These types of studies are now performed on cells from the blastocyst stage (since this is 
now the preferred biopsy stage, used by the novel genome wide platforms) and allow the evaluation 
of the level of mosaicism [8] and types of aneuploidy. Our initial results, albeit on embryos we knew 
to be aneuploid, indicated patterns of mosaicism more complex that previously appreciated.  
In a second round of experiments, we extended the study further on a larger number of embryos, 
some for the same patient. In these set of experiments we looked at a larger number of embryos, 
some from the same patient. Figure 3 shows example images on each of the embryos and table 3 
summarises the results. 
Taken together, our results suggest that 24 chromosome FISH has great potential in unravelling the 
mysteries of chromosome mosaicism, one of the most hotly debated topics currently in 
preimplantation genetics. The ability to assay every chromosome on a cell by cell basis is particularly 
attractive. Our results suggest that embryo aneuploidy is not highly significantly correlated to 
maternal age, probably due, in part, to the large preponderance of post-zygotic (mitotic) errors. Of 
these, chromosome loss is the most common (presumably due to anaphase lag), followed by 
chromosome gain (endoreplication) whereas 3:1 mitotic non-disjunction of chromosomes appears 
to be rare in human preimplantation development.  
 
Nuclear Organisation 
 Another feature, with a more research oriented scope that the 24-FISH platform can provide is the 
simultaneous assessment of the nuclear organization in preimplantation embryos. The term nuclear 
organisation or “nuclear architecture” describes the spatial and temporal topology of chromosomes 
or sub-chromosomal compartments (e.g. genes) within the nucleus that forms a fully functional 
nuclear landscape. With the popularisation of FISH in the early 1990s allowing visualisation of 
chromosomes in the interphase nucleus came a flurry of studies that sought to address chromosome 
position in situ. These led to the realisation of the now widely accepted concept that, within the 
nucleus, chromosomes are not randomly distributed but are organised into discrete regions known 
as chromosome territories (CTs) [41-45]. Between these chromosome territories, inter-chromatin 
compartments containing macromolecular complexes are positioned. These are required for DNA 
replication, transcription, gene splicing and DNA repair and as such, the location of a chromosome 
within the nuclear volume is directly related to its accessibility to nuclear machinery [41] . The strict 
order of chromosome territories is believed to play a vital role in the regulation of gene expression, 
DNA replication, damage, and repair, controlling all cellular functions and development [41, 46-53].  
Evidence to support the hypothesis for a link between position and function is provided from studies 
of cellular differentiation processes. Examples include the repositioning of the immunoglobulin gene 
cluster, the Mash1 locus during neural induction [54] [55] the HoxB1 gene in mouse embryos [56], 
the repositioning of adipogenesis genes during porcine mesenchymal stem cell adipogenesis [57] 
and sex chromosome movement during porcine spermatogenesis  [58] just to name a few. In 
addition evidence supports that perturbation of nuclear organisation is correlated with certain 
diseases like laminopathies [59, 60] and certain cancers (promyelotic leukaemia, breast) [61]. 
Because of observations in different cell types and organisms [62, 63] proximity patterns of 
chromosomes, were identified leading to the proposal of two models (gene density and 
chromosome size) for the radial arrangement of CTs. 
 
The gene density model for nuclear organization postulates that gene rich chromosomes occupy 
more central regions of the nuclear volume whereas gene poor chromosomes are localized toward 
the periphery [64-70]. This model originated from observations in proliferating lymphoblasts and 
fibroblasts and can be seen in primates, old world monkeys, rodents, birds (excluding chicken) and 
cattle. The chromosome size model of nuclear organization originated from observations in flat 
ellipsoid fibroblasts, quiescent, and senescent cells. In this scenario smaller chromosomes are 
positioned towards the nuclear interior and larger chromosomes toward the outermost regions of 
the nuclear membrane [71-73]. Furthermore, the chromocentric model (seen in human sperm) 
where chromosomes are positioned with their centromeres toward the interior of the nucleus 
(forming chromocentres) and their telomeres extending toward the nuclear periphery forming 
dimers and tetramers [74-77]. 
 
Other models proposed later, included the chromosome territory interchromatin compartment (CT-
IC) model, which described the existence of two domains in the nuclei called chromosome territories 
(CT) and interchromatin compartments (IC) [78] the lattice model, which suggested that fibres from 
different chromosomes were able to intermingle to a certain extent at the edges of CTs [79] and 
finally, the interchromatin network (ICN) model, which explained the long range intermingling of 
distal chromosome regions belonging to the same chromosome, or between regions of different 
chromosomes via the ‘looping out’ of chromatin within and between chromosome territories 
respectively [48].  
 
Although there are many studies that have addressed nuclear organisation in a range of cell types 
from a wide spectrum of species, few studies have investigated nuclear organisation in the human 
embryo, and only one study has assessed the positioning of all 24 chromosomes [38]. Moreover, 
evidence presented thus far is not clear-cut. In studies that have assessed the nuclear positions of a 
subset of chromosomes (13, 16, 18, 21, 22, X and Y) in cleavage stage embryos (day 3-4), Mackenzie 
et al. [80] found central positioning of chromosomes 13, 18, 21 and X and peripheral positioning of 
chromosomes 16, 22 and Y, whereas both studies from Diblik  [81] and Finch [82] found a random 
distribution of these chromosomes (with the exception of chromosome 18, that showed a central 
localisation [81]). The reason behind the discrepancies observed could be due to number of factors, 
both technical (e.g. method of fixation and method of position analysis), or biological (e.g. the 
quality of the embryos used, which in any study akin to these, were likely deemed unsuitable for 
transfer due to developmental, morphological or genetic abnormalities). Nonetheless, despite these 
differences, there is clear evidence to suggest that nuclear organisation of totipotent cells 
originating from the cleavage stage preimplantation human embryo differs significantly to that of 
committed cell lines [38, 82], suggesting a functional role for chromosome positioning during 
development and differentiation. Furthermore, there is evidence to suggest that although 
chromosome positioning remains unperturbed in embryos with poor morphology compared to 
those of higher morphological grade, nuclear organisation is significantly altered in embryos with 
chromosome copy number abnormalities [80-82]. The biological mechanism behind this 
phenomenon remains as yet rather elusive, as shown by the fact that the nature and extent of re-
organisation in aneuploid blastomeres is not consistent among the literature. While MacKenzie et al. 
[80] report that an extra copy of a specific chromosome results in re-distribution from central to 
peripheral regions of the nucleus, the study from Finch et al. [82] reports that euploid blastomeres 
adopt a relaxed state of nuclear organisation in which chromosomes were positioned randomly and 
that aneuploidy was  associated with central positioning of chromosomes [80, 82]. The study from 
the Diblik group on the other hand, identified that of the chromosomes assessed, only chromosome 
18 showed differential positioning in blastomeres possessing an extra copy, and that this difference 
was characterised by a shift from a random to a peripheral location [81]. It is noteworthy however, 
that Finch et al. [82] highlight the difficulty in extrapolating conclusions regarding the shift of specific 
chromosomes in relation to an extra copy (of the same chromosome), given the small subset of 
chromosomes assayed and any additional chromosomal abnormalities in chromosomes that were 
not investigated.  
 
Assessing nuclear organization of human embryos by 24 chromosome FISH 
With the introduction of 24-colour FISH, the aforementioned shortfall could be addressed and 
previous observations could be expanded upon with the inclusion of the topology for each 
chromosome in the karyotype [38]. In order to measure nuclear organization we extrapolated 3D 
data from 2D preparations thus: For each probe, the question was asked whether a non-random 
pattern of distribution of the FISH signal could be identified in each embryo. If so, we asked which 
part of the nucleus was preferentially occupied with reference to five “shells,” each representing 
equal portions of the nucleus (from interior to periphery). We employed an ImageJ “macro” that 
divided each image of a nucleus into separate RGB planes (red and green for two of the six signals, 
blue for the DAPI counterstain) and then converted the blue image to a binary mask from which 5 
concentric regions of interest (shells) of equal area were created. The proportion of signal in each 
channel contained within each shell was measured relative to the total signal for that channel within 
the area covered by the binary mask. The output of these results was pasted to an Excel spreadsheet 
for statistical analysis. To compensate for the fact that we were deriving 3D information from a 
flattened 2D object, the proportion of signal within each shell was normalised against the DAPI 
density measured within that shell as a function of the amount of DNA measured. The results are 
represented as a histogram and a χ2 “goodness of fit” test was performed to test whether the 
nuclear position of the signal was non-randomly distributed to a specific shell (p<0.05) or “not 
discernible from a random pattern” (NDRP).  
 
As shown in table 4, by and large, our results showed that, human embryos at the morula or 
blastocyst stage (day 4 or 5 respectively) appear to adopt a chromocentric pattern of nuclear 
organisation, with almost all centromeric signals residing in the inner-most regions of the nuclear 
volume (with the exception of chromosome 5 predominantly identified at the nuclear periphery and 
chromosome 19, which showed a random distribution) [38]. This was an interesting finding that was 
consistent with results from studies in embryos from mice [83]. However the chromocentric 
arrangement seen in mice embryos appears to be consistent throughout development [83], whereas 
evidence for this in human embryos is partial from cleavage stage data, where 3 out of the 8 
chromosomes investigated had a peripheral distribution [80]. Since nuclear organisation is subjected 
to alteration during the process of differentiation in other cell types [58, 63, 84-93], it is possible that 
earlier findings from a small number of chromosomes assessed in cleavage stage embryos indicate a 
more fluid nature of nuclear organisation in totipotent blastomeres. At the blastocyst stage 
however, which is the earliest differentiation event, a more ordered organisation with spatial and 
temporal cues important for embryo development appears. Supporting this evidence is the fact that 
committed cells (e.g., lymphocytes) adopt a different pattern of organization compared to embryos 
(assessed on day 3 or 5 post fertilisation), as shown in table 4 [38]. In the future it would be 
interesting to compare the organisation by following an embryo (surplus to IVF) from blastomere to 
blastocyst stage, but more importantly apply this technique into a larger number of cells from 
blastocyst stage and stratify any organisation data based on the indication for IVF (e.g. AMA, RIF). 
 
In terms of the organisation of preimplantation embryos and aneuploidy status, our results have not 
revealed a difference between the individual cells (from the whole embryo) that were classified as 
“normal” for the needs of the study compared to the aneuploid ones. A partial explanation for this 
could be either due to the probes used, that targeted a predominantly heterochromatic proportion 
of the chromosome, small in size and therefore difficult to observe a potential noticeable difference 
using it as a single reference point, or more importantly the fact that the single cells assessed from 
the whole embryo, originated from unsuitable for transfer blastocysts that were probably already 
compromised in terms of their developmental potential. 
 
The use of different probes (e.g. whole chromosome territories or a combination of reference points 
on the chromosome) and if applicable better quality blastocysts could help to address the issues 
regarding ploidy and genome organisation when the whole karyotype is investigated with 24 colour 
FISH. 
 
Furthermore, a better appreciation about the organisation of preimplantation embryos will be 
possible by moving from 2D to 3D and the development of a more automated protocol that will 
allow to render the captured images into 3D models. Software like that is currently available. 
Currently, all studies that have assessed nuclear organisation in the blastomeres of human embryos 
have utilised 2D analysis techniques using centromere specific probes. The use of whole 
chromosome paints, combined with 3D analysis will provide a more complete map about the 
topology of chromosomes and how this might be related to the development of the human 
preimplantation embryo. 
Conclusion  
In conclusion, it seems that, while FISH is mostly “dead and buried” for the mainstream use in PGS, it 
still has a place for the assessment of mosaicism and for the study of nuclear organization. The 
development of a 24 chromosome protocol extends the power of this analysis and we would like to 
hope that it will still find an application as a result.  
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